Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Flibanserin: Phase III start</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

Boehringer Ingelheim will begin the Phase III ORCHID trial of oral flibanserin in pre-menopausal women. ......

Endocrine / Metabolic

Genitourinary

Flibanserin: Phase III start

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts 

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data Coverage

BCIQ Data

All Events

At the East-West Summit, you will meet key players looking to globalize innovation from across Asia.